1. The Effect of the Hypocholesterolemic Drug Clofibrate on Liver Mitochondrial Biogenesis
- Author
-
Jana M. Bednarek, Arlene D. Albert, and Adrian R.L. Gear
- Subjects
medicine.medical_specialty ,Proteases ,Methionine ,Protease ,Clofibrate ,Arginine ,biology ,medicine.medical_treatment ,Acid phosphatase ,Cell Biology ,Mitochondrion ,Biochemistry ,chemistry.chemical_compound ,Endocrinology ,chemistry ,Mitochondrial biogenesis ,Internal medicine ,medicine ,biology.protein ,Molecular Biology ,medicine.drug - Abstract
The hypocholesterolemic drug clofibrate raises hepatic levels of mitochondria by over 100 %, with maximum increase at 2 to 4 days after drug administration, and a slow rise continuing at 10 days. This time response was similar to that seen after partial hepatectomy. However, several clear differences exist. During the doubling in mitochondrial content, no change in particle size or specific content of DNA or RNA was observed, whereas during liver regeneration the former decreases by 50 % and the latter increases by 300 %. The half-life of 5.8 days for normal mitochondria was not altered significantly by clofibrate, using [guanidinio-14C]arginine. However, the initial rate of short term incorporation of [35S]methionine into control mitochondria in vivo was 60 % of that for drug-tested animals, while the in vitro efficiency of [14C]leucine incorporation was reversed; mitochondria from drug-treated animals were about 61 % as active as those from controls. Enzyme activity of drug-treated animals was not significantly altered for inner membrane or matrix enzymes. However, a 30 to 40 % fall in specific activity of three outer membrane enzymes was noted from 2 to 15 days. This resembles changes seen during early liver regeneration. One striking action of clofibrate was to inhibit the neutral protease activity of mitochondria. Even at 2 days on clofibrate, neutral protease activity was inhibited to 62 % of the control value of 0.334 µmole of amino acid per hour per mg of protein. Inhibition was a maximum of 50 % at 6 days, and was still at 63 % at 20 days. Clofibrate added in vitro had negligible influence on neutral protease activity. The inhibition was independent of lysosomes since the protease activity of purified lysosomes was neither inhibited, nor was acid phosphatase activity in whole homogenates or the purified mitochondrial fractions changed during drug treatment. The endogenous amino acid content of 0.032 µmole per mg protein remained constant during the stimulation in bio-genesis. The results of this study on clofibrate support a hypothesis that net levels of hepatic mitochondria may be controlled by the activity of their own neutral proteases. A possible action is to degrade newly synthesized mitochondrial proteins, which may be structural or binding, such that a lowered protease activity would raise their levels and thereby increase mitochondrial content.
- Published
- 1974
- Full Text
- View/download PDF